Folate metabolizing enzyme gene polymorphisms can lead to impaired folate metabolism. As mentioned above, 5,10-methylenetetrahydrofolate reductase is generally classified into three genotypes.

This makes the conversion of folic acid in the body difficult.
Carriers of the MTHFR677TT gene are said to have a severe impairment of folate metabolism.
Carriers of the MTHFR677CT gene are said to have a moderate impairment of folate metabolism.
These genotypes, not only lead to low folate utilisation, but also predispose to certain diseases.
Genetic testing is now available to identify mutations in different folate metabolising enzymes to determine whether they have a disorder of folate metabolism, so that countermeasures can be planned to remedy their deficiencies.

After years of work, scientists have developed Magnafolate.
Magnafolate is the unique patent protected C crystalline L-5-Methyltetrahydrofolate Calcium salt (L-5-MTHF Ca) which can get the purest and most stable bio-active folate.
Magnafolate can be absorbed directly, no metabolism, applied for all people(including MTHFR mutant population).

Español
Português
русский
Français
日本語
Deutsch
tiếng Việt
Italiano
Nederlands
ภาษาไทย
Polski
한국어
Svenska
magyar
Malay
বাংলা ভাষার
Dansk
Suomi
हिन्दी
Pilipino
Türkçe
Gaeilge
العربية
Indonesia
Norsk
تمل
český
ελληνικά
український
Javanese
فارسی
தமிழ்
తెలుగు
नेपाली
Burmese
български
ລາວ
Latine
Қазақша
Euskal
Azərbaycan
Slovenský jazyk
Македонски
Lietuvos
Eesti Keel
Română
Slovenski
मराठी
Srpski језик 







Online Service